Outcome of Board Meeting for declaring the financial results (Standalone & Consolidated) for the financial year ended March 31, 2026.
RAINBOW · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Rainbow Children's Medicare Limited reported audited FY26 results with standalone revenue of ₹15,457 million (up 6.3% YoY) and consolidated revenue of ₹17,031 million (up 12.4% YoY). Standalone PAT grew to ₹2,500 million from ₹2,376 million, while consolidated PAT reached ₹2,815 million from ₹2,442 million. The Board recommended a final dividend of ₹3.50 per share (35% on face value). An exceptional item of ₹15.39 million was recognized due to new labour codes implementation. The company also completed acquisition of Prashanthi Medicare Private Limited (76% stake) in July 2025, contributing ₹191.52 million in revenue. Statutory auditors issued an unmodified (clean) opinion on both standalone and consolidated results.
Positive signals include strong PAT growth of 15.3% on consolidated basis and shareholder returns via dividend. The clean audit opinion removes concerns about financial reporting quality. Revenue growth is healthy though below 20%, and the exceptional item is a one-time charge unlikely to recur.